Multiple Small Feedings of the Mind

Current Topics

Formats: MP3, CD, iPod Audio, AudioPoint for Computer and iPod
	Pre-Course Sessions
	Additional Topics
	Associates, Residents and Fellows in Training
	Cardiology
	Career and Professionalism
	Clinical Pearls
	Clinical Pharmacology
	Endocrinology
	End-of-Life and Palliative Care
	Ethics and Health Policy
	Gastroenterology and Hepatology
	Geriatric Medicine
	Health Information Technology
	Hematology
	Hospital Medicine
	Infectious Diseases
	Medical Practice Management
	Medical Student Programs
	Multiple Small Feedings of the Mind
	Nephrology and Hypertension
	Neurology
	Oncology
	Ophthalmology and Otolaryngology
	Perioperative Medicine
	Psychiatry
	Pulmonary Diseases and Critical Care
	Rheumatology and Allergy & Immunology
	Updates
	Women's Health

MSFM: Infectious Diseases, Psychiatry, and Pulmonary Medicine

Session #: 850-206
Presenter(s): Carol L. Alter, MD; Dana Zappetti, MD; Judy Tung, MD, Member; Robert Orenstein, FIDSA, AAHIVM, DO
Session Length: 1 hr. 30 min.
Event: Internal Medicine 2010
Date: April 22-24, 2010

Purchase Media - Session #: 850-206
Description	Price	Qty.	Cart
Audio CD	$17.95		buy now
MP3 CD-ROM	$17.95		buy now
iPod Audiobook CD-ROM	$17.95		buy now
AudioPoint for your computer	$24.95		buy now
AudioPoint for your iPod	$24.95		buy now
Download MP3 & iTunes Audiobook File	$17.95		buy now
Download AudioPoint for iPod	$24.95		buy now

MSFM 003
MSFM: Infectious Diseases, Psychiatry, and Pulmonary Medicine

Clinical questions to be addressed:

Infectious Diseases

What is the role of serum procalcitonin in the management of lower respiratory tract infections? Does it reduce the use of unnecessary antibiotics?
What is the efficacy of the H1N1 vaccine in mitigating symptoms and/or limiting pandemic spread?
What are evidence-based methods for the prevention of refractory Clostridium difficile colitis? When and how should testing be performed for Clostridium difficile antibiotic sensitivity?

Psychiatry

What psychiatric screens are recommended for the evaluation of Medically Unexplained Symptoms? What treatment modalities and followup are most effective in these patients?
When should medication trials for depression be augmented and when should they be switched?
How should treatment of chronic pain differ in a patient with a history of addiction?

Pulmonary

How does the general internist evaluate the efficacy of continuous positive airway pressure for patients with obstructive sleep apnea? How is treatment failure defined?
In the treatment of chronic obstructive pulmonary disease and asthma, are there evidence-based differences between the various inhalant delivery vehicles (e.g., dry powder inhalers vs. metered-dose inhalers)?
When should phosphodiesterase type 5 (PDE5) inhibitors (e.g., sildenafil) and/or endothelin-receptor antagonists (e.g., bosentan) be used for patients with pulmonary hypertension?